Table 2.
Demographics and Drug-Use Details
| Mean | S.E.M | Range | |
|---|---|---|---|
| Age | 36.6 | 1.3 | 29.0–39.0 |
| Weight (kgs) | 81.4 | 4.9 | 65.9–102.3 |
| MJ | 4.2 | 0.9 | 2.0–7.0 |
| Days/Week | |||
| MJ | 4.8 | 1.8 | 1.0–10.5 |
| Joints/Daya | |||
| Alcohol Days/Weekb | 1.1 | 0.4 | 0.25–3.0 |
| Alcohol | 5.6 | 1.5 | 1.5–10.0 |
| Drinks/Occasionb | |||
| Cigarettes/Dayc | 15.1 | 4.9 | 0.3–20.0 |
| Participant | Race | Education | HIV Medications |
Cocaine Use? |
Heroin Use? |
Other Drug Use? |
|---|---|---|---|---|---|---|
| 1 | AA | HS, some college |
lopinavir ritonavir azithromycin sulfamethoxazole abacavir |
Occasional | No | No |
| 2 | Caucasian | HS, some college |
tenofovir ritonavir didanosine atazanavir |
No | Occasional | LSD, Ecstasy |
| 3 | Mixed | Technical schooling |
tenofovir lamivudine efavirenz |
No | No | No |
| 4 | Mixed | B.A. | nevirapine lamivudine zidovudine gemfibrozil |
No | No | No |
| 5 | AA | 8th grade | tenofovir lamivudine efavirenz |
Occasional | No | LSD |
| 6 | AA | HS, some college |
sulfamethoxazole ritonavir didanosine atazanavir loperamide tenofovir emtricitabine |
No | No | No |
| 7 | AA | 10th grade | nevirapine lamivudine zidovudine |
No | No | No |
a
Estimated based on a rate of 3 marijuana joints per marijuana blunt; N = 6 because 1 participant reported smoking 1.5 bowls of unknown size per day.
b
N = 6 who reported past month alcohol consumption.
c
N = 4 who reported past month cigarette smoking.
S.E.M = Standard Error of the Mean; kgs = kilograms; MJ = marijuana; AA = African American; HS = completed high school; B.A. = completed Bachelor of Arts; LSD = lysergic acid diethylamide.